Bioelectronics Corp Stock EBITDA

BIEL Stock  USD 0.0003  0.0001  50.00%   
Bioelectronics Corp fundamentals help investors to digest information that contributes to Bioelectronics Corp's financial success or failures. It also enables traders to predict the movement of Bioelectronics Pink Sheet. The fundamental analysis module provides a way to measure Bioelectronics Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bioelectronics Corp pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Bioelectronics EBITDA Analysis

Bioelectronics Corp's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Bioelectronics Corp EBITDA

    
  (1.36 M)  
Most of Bioelectronics Corp's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bioelectronics Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

According to the company disclosure, Bioelectronics Corp reported earnings before interest,tax, depreciation and amortization of (1.36 Million). This is 100.16% lower than that of the Healthcare sector and 100.21% lower than that of the Medical Devices industry. The ebitda for all United States stocks is 100.03% higher than that of the company.

Bioelectronics EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bioelectronics Corp's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Bioelectronics Corp could also be used in its relative valuation, which is a method of valuing Bioelectronics Corp by comparing valuation metrics of similar companies.
Bioelectronics Corp is currently under evaluation in ebitda category among related companies.

Bioelectronics Fundamentals

About Bioelectronics Corp Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Bioelectronics Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioelectronics Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioelectronics Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. The company was incorporated in 2000 and is headquartered in Frederick, Maryland. BIOELECTRONICS CORP operates under Medical Devices classification in the United States and is traded on OTC Exchange.

Pair Trading with Bioelectronics Corp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioelectronics Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioelectronics Corp will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Bioelectronics Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bioelectronics Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bioelectronics Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bioelectronics Corp to buy it.
The correlation of Bioelectronics Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bioelectronics Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bioelectronics Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bioelectronics Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Bioelectronics Corp Piotroski F Score and Bioelectronics Corp Altman Z Score analysis.
Note that the Bioelectronics Corp information on this page should be used as a complementary analysis to other Bioelectronics Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Bioelectronics Pink Sheet analysis

When running Bioelectronics Corp's price analysis, check to measure Bioelectronics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioelectronics Corp is operating at the current time. Most of Bioelectronics Corp's value examination focuses on studying past and present price action to predict the probability of Bioelectronics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioelectronics Corp's price. Additionally, you may evaluate how the addition of Bioelectronics Corp to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Please note, there is a significant difference between Bioelectronics Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioelectronics Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioelectronics Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.